2018
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. Journal Of The National Comprehensive Cancer Network 2018, 16: 693-702. PMID: 29891520, DOI: 10.6004/jnccn.2018.0056.Peer-Reviewed Original ResearchConceptsPrimary neuroendocrine tumorNeuroendocrine tumorsAdrenal tumorsManagement of NETsLocoregional advanced diseaseNCCN Guidelines InsightsAdrenal gland tumorsAdvanced diseaseNCCN guidelinesAdult patientsDistant metastasisGastrointestinal tractGland tumorsTumorsNeuroendocrineManagement optionsGuidelinesPatientsPheochromocytomaMetastasisParagangliomaDiseaseTract
2016
Management of Small Nonfunctional Pancreatic Neuroendocrine Tumors
Grisotti G, Khan S. Management of Small Nonfunctional Pancreatic Neuroendocrine Tumors. Difficult Decisions In Surgery: An Evidence-Based Approach 2016, 641-653. DOI: 10.1007/978-3-319-27365-5_56.Peer-Reviewed Original ResearchNonfunctional pancreatic neuroendocrine tumorsPancreatic neuroendocrine tumorsSmall Nonfunctional Pancreatic Neuroendocrine TumorsNeuroendocrine tumorsSmall pancreatic neuroendocrine tumorsType 1Multiple endocrine neoplasia type 1Von Hippel-Lindau diseaseRole of surgeryFuture prospective studiesStandard of careHippel-Lindau diseaseNeurofibromatosis type 1Selective treatment approachSurgical resectionProspective studyNonsurgical approachHepatopancreaticobiliary surgeryMalignant potentialPancreatic tumorsPNET diagnosisSmall tumorsTuberous sclerosisCancer susceptibility syndromeTreatment approaches